Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.51 +0.29 (+4.02%)
As of: Oct 2, 2026 · 11:28 AM EDT

Cartesian Therapeutics (RNAC) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Cartesian Therapeutics' Depreciation & Amortization (CF) was $779,000 in Q2 2026, up 32.3% from $589,000 a year earlier and up 26.7% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cartesian Therapeutics' Depreciation & Amortization (CF) was $2.61 million through Jun 30, 2026, up 3.6% year-over-year; for FY2025, it came in at $2.96 million, up 157.1% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $1.15 million in FY2024 (+36.5%), $843,000 in FY2023 (-34.5%), $1.29 million in FY2022 (+2.8%) and $1.25 million in FY2021 (+70.6%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) since Q1 2025.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in seven of the last eight quarters, with growth averaging 123.1%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2025 (growth of 531.7%); the worst was Q2 2023 (a decline of 49.0%).
  • Per Business Quant data, RNAC's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $615,000 (Q1 2026), $608,000 (Q4 2025) and $606,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Cartesian Therapeutics 216.57 Mn 216.57 Mn - 779,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 779,000.00
Mar 31, 2026 615,000.00
Dec 31, 2025 608,000.00
Sep 30, 2025 606,000.00
Jun 30, 2025 589,000.00
Mar 31, 2025 1.16 Mn
Dec 31, 2024 486,000.00
Sep 30, 2024 286,000.00
Jun 30, 2024 196,000.00
Mar 31, 2024 183,000.00
Dec 31, 2023 272,000.00
Sep 30, 2023 189,000.00
Jun 30, 2023 176,000.00
Mar 31, 2023 206,000.00
Dec 31, 2022 241,000.00
Sep 30, 2022 350,000.00
Jun 30, 2022 345,000.00
Mar 31, 2022 351,000.00
Dec 31, 2021 401,000.00
Sep 30, 2021 339,000.00
API Access

Cartesian Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RNAC&period=max&api_key=YOUR_API_KEY